ANTHRACYCLINE RELATED CARDIOTOXICITY IN BREAST CANCER
Clinical trials for ANTHRACYCLINE RELATED CARDIOTOXICITY IN BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new ANTHRACYCLINE RELATED CARDIOTOXICITY IN BREAST CANCER trials appear
Sign up with your email to follow new studies for ANTHRACYCLINE RELATED CARDIOTOXICITY IN BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a common cholesterol pill shield hearts from chemo damage?
Prevention Not yet recruitingThis study is testing whether the drug rosuvastatin can protect the heart from damage caused by a common type of breast cancer chemotherapy. 400 women starting this chemotherapy will take either rosuvastatin or a placebo pill daily for one year. The main goal is to see if the dru…
Matched conditions: ANTHRACYCLINE RELATED CARDIOTOXICITY IN BREAST CANCER
Phase: PHASE4 • Sponsor: Shiraz University of Medical Sciences • Aim: Prevention
Last updated Mar 27, 2026 12:40 UTC
-
Virtual reality goggles aim to protect Survivors' hearts
Knowledge-focused Not yet recruitingThis study is testing a virtual reality (VR) education program designed to help breast cancer survivors learn about potential heart risks from their cancer treatments. The program teaches survivors about these risks and suggests healthy lifestyle changes, like physical activity, …
Matched conditions: ANTHRACYCLINE RELATED CARDIOTOXICITY IN BREAST CANCER
Phase: NA • Sponsor: Virginia Commonwealth University • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:33 UTC